Author:
Roden Michael,Weng Jianping,Eilbracht Jens,Delafont Bruno,Kim Gabriel,Woerle Hans J,Broedl Uli C
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia;DeFronzo;Diabetes Obes Metab,2012
2. Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans;List;Kidney Int Suppl,2011
3. Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors;Grempler;Diabetes Obes Metab,2012
4. A phase IIb, randomised, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes;Ferrannini;Diabetes Obes Metab,2013
5. Efficacy and safety of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycemia;Rosenstock;Diabetes Obes Metab,2013
Cited by
382 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献